Global Gene Synthesis Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Summary
Gene synthesis refers to chemically synthesizing a strand of DNA base-by-base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built.
According to APO Research, The global Gene Synthesis market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Gene Synthesis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Gene Synthesis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Gene Synthesis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Gene Synthesis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Gene Synthesis include Genescript, GeneArt (Thermofischer), IDT, DNA 2.0 (ATUM), OriGene, BBI, Genewiz, Eurofins Genomics and Gene Oracle, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Gene Synthesis, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Gene Synthesis, also provides the value of main regions and countries. Of the upcoming market potential for Gene Synthesis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gene Synthesis revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Gene Synthesis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Gene Synthesis company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Gene Synthesis segment by Company
1. To analyze and research the global Gene Synthesis status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Gene Synthesis key companies, revenue, market share, and recent developments.
3. To split the Gene Synthesis breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Gene Synthesis market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Gene Synthesis significant trends, drivers, influence factors in global and regions.
6. To analyze Gene Synthesis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Synthesis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Synthesis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Synthesis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Synthesis industry.
Chapter 3: Detailed analysis of Gene Synthesis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Gene Synthesis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Gene Synthesis in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
Gene synthesis refers to chemically synthesizing a strand of DNA base-by-base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built.
According to APO Research, The global Gene Synthesis market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Gene Synthesis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Gene Synthesis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Gene Synthesis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Gene Synthesis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Gene Synthesis include Genescript, GeneArt (Thermofischer), IDT, DNA 2.0 (ATUM), OriGene, BBI, Genewiz, Eurofins Genomics and Gene Oracle, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Gene Synthesis, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Gene Synthesis, also provides the value of main regions and countries. Of the upcoming market potential for Gene Synthesis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gene Synthesis revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Gene Synthesis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Gene Synthesis company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Gene Synthesis segment by Company
- Genescript
- GeneArt (Thermofischer)
- IDT
- DNA 2.0 (ATUM)
- OriGene
- BBI
- Genewiz
- Eurofins Genomics
- Gene Oracle
- SBS Genetech
- Bio Basic
- Below 1000 bp
- 1001-3000 bp
- 3001-5000 bp
- Above 5000 bp
- Commercial Research
- Academic Research
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Gene Synthesis status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Gene Synthesis key companies, revenue, market share, and recent developments.
3. To split the Gene Synthesis breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Gene Synthesis market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Gene Synthesis significant trends, drivers, influence factors in global and regions.
6. To analyze Gene Synthesis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Synthesis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Synthesis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Synthesis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Synthesis industry.
Chapter 3: Detailed analysis of Gene Synthesis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Gene Synthesis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Gene Synthesis in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Gene Synthesis Market Size, 2019 VS 2023 VS 2030
1.3 Global Gene Synthesis Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 GENE SYNTHESIS MARKET DYNAMICS
2.1 Gene Synthesis Industry Trends
2.2 Gene Synthesis Industry Drivers
2.3 Gene Synthesis Industry Opportunities and Challenges
2.4 Gene Synthesis Industry Restraints
3 GENE SYNTHESIS MARKET BY COMPANY
3.1 Global Gene Synthesis Company Revenue Ranking in 2023
3.2 Global Gene Synthesis Revenue by Company (2019-2024)
3.3 Global Gene Synthesis Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Gene Synthesis Company Manufacturing Base & Headquarters
3.5 Global Gene Synthesis Company, Product Type & Application
3.6 Global Gene Synthesis Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Gene Synthesis Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Gene Synthesis Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 GENE SYNTHESIS MARKET BY TYPE
4.1 Gene Synthesis Type Introduction
4.1.1 Below 1000 bp
4.1.2 1001-3000 bp
4.1.3 3001-5000 bp
4.1.4 Above 5000 bp
4.2 Global Gene Synthesis Sales Value by Type
4.2.1 Global Gene Synthesis Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Gene Synthesis Sales Value by Type (2019-2030)
4.2.3 Global Gene Synthesis Sales Value Share by Type (2019-2030)
5 GENE SYNTHESIS MARKET BY APPLICATION
5.1 Gene Synthesis Application Introduction
5.1.1 Commercial Research
5.1.2 Academic Research
5.2 Global Gene Synthesis Sales Value by Application
5.2.1 Global Gene Synthesis Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Gene Synthesis Sales Value by Application (2019-2030)
5.2.3 Global Gene Synthesis Sales Value Share by Application (2019-2030)
6 GENE SYNTHESIS MARKET BY REGION
6.1 Global Gene Synthesis Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Gene Synthesis Sales Value by Region (2019-2030)
6.2.1 Global Gene Synthesis Sales Value by Region: 2019-2024
6.2.2 Global Gene Synthesis Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Gene Synthesis Sales Value (2019-2030)
6.3.2 North America Gene Synthesis Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Gene Synthesis Sales Value (2019-2030)
6.4.2 Europe Gene Synthesis Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Gene Synthesis Sales Value (2019-2030)
6.5.2 Asia-Pacific Gene Synthesis Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Gene Synthesis Sales Value (2019-2030)
6.6.2 Latin America Gene Synthesis Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Gene Synthesis Sales Value (2019-2030)
6.7.2 Middle East & Africa Gene Synthesis Sales Value Share by Country, 2023 VS 2030
7 GENE SYNTHESIS MARKET BY COUNTRY
7.1 Global Gene Synthesis Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Gene Synthesis Sales Value by Country (2019-2030)
7.2.1 Global Gene Synthesis Sales Value by Country (2019-2024)
7.2.2 Global Gene Synthesis Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.3.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.4.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.5.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.6.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.7.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.8.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.9.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.10.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.11.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.12.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.13.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.14.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.15.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.16.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.17.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.18.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.19.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.20.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.21.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Genescript
8.1.1 Genescript Comapny Information
8.1.2 Genescript Business Overview
8.1.3 Genescript Gene Synthesis Revenue and Gross Margin (2019-2024)
8.1.4 Genescript Gene Synthesis Product Portfolio
8.1.5 Genescript Recent Developments
8.2 GeneArt (Thermofischer)
8.2.1 GeneArt (Thermofischer) Comapny Information
8.2.2 GeneArt (Thermofischer) Business Overview
8.2.3 GeneArt (Thermofischer) Gene Synthesis Revenue and Gross Margin (2019-2024)
8.2.4 GeneArt (Thermofischer) Gene Synthesis Product Portfolio
8.2.5 GeneArt (Thermofischer) Recent Developments
8.3 IDT
8.3.1 IDT Comapny Information
8.3.2 IDT Business Overview
8.3.3 IDT Gene Synthesis Revenue and Gross Margin (2019-2024)
8.3.4 IDT Gene Synthesis Product Portfolio
8.3.5 IDT Recent Developments
8.4 DNA 2.0 (ATUM)
8.4.1 DNA 2.0 (ATUM) Comapny Information
8.4.2 DNA 2.0 (ATUM) Business Overview
8.4.3 DNA 2.0 (ATUM) Gene Synthesis Revenue and Gross Margin (2019-2024)
8.4.4 DNA 2.0 (ATUM) Gene Synthesis Product Portfolio
8.4.5 DNA 2.0 (ATUM) Recent Developments
8.5 OriGene
8.5.1 OriGene Comapny Information
8.5.2 OriGene Business Overview
8.5.3 OriGene Gene Synthesis Revenue and Gross Margin (2019-2024)
8.5.4 OriGene Gene Synthesis Product Portfolio
8.5.5 OriGene Recent Developments
8.6 BBI
8.6.1 BBI Comapny Information
8.6.2 BBI Business Overview
8.6.3 BBI Gene Synthesis Revenue and Gross Margin (2019-2024)
8.6.4 BBI Gene Synthesis Product Portfolio
8.6.5 BBI Recent Developments
8.7 Genewiz
8.7.1 Genewiz Comapny Information
8.7.2 Genewiz Business Overview
8.7.3 Genewiz Gene Synthesis Revenue and Gross Margin (2019-2024)
8.7.4 Genewiz Gene Synthesis Product Portfolio
8.7.5 Genewiz Recent Developments
8.8 Eurofins Genomics
8.8.1 Eurofins Genomics Comapny Information
8.8.2 Eurofins Genomics Business Overview
8.8.3 Eurofins Genomics Gene Synthesis Revenue and Gross Margin (2019-2024)
8.8.4 Eurofins Genomics Gene Synthesis Product Portfolio
8.8.5 Eurofins Genomics Recent Developments
8.9 Gene Oracle
8.9.1 Gene Oracle Comapny Information
8.9.2 Gene Oracle Business Overview
8.9.3 Gene Oracle Gene Synthesis Revenue and Gross Margin (2019-2024)
8.9.4 Gene Oracle Gene Synthesis Product Portfolio
8.9.5 Gene Oracle Recent Developments
8.10 SBS Genetech
8.10.1 SBS Genetech Comapny Information
8.10.2 SBS Genetech Business Overview
8.10.3 SBS Genetech Gene Synthesis Revenue and Gross Margin (2019-2024)
8.10.4 SBS Genetech Gene Synthesis Product Portfolio
8.10.5 SBS Genetech Recent Developments
8.11 Bio Basic
8.11.1 Bio Basic Comapny Information
8.11.2 Bio Basic Business Overview
8.11.3 Bio Basic Gene Synthesis Revenue and Gross Margin (2019-2024)
8.11.4 Bio Basic Gene Synthesis Product Portfolio
8.11.5 Bio Basic Recent Developments
9 CONCLUDING INSIGHTS
10 APPENDIX
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
1.1 Product Definition
1.2 Global Gene Synthesis Market Size, 2019 VS 2023 VS 2030
1.3 Global Gene Synthesis Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 GENE SYNTHESIS MARKET DYNAMICS
2.1 Gene Synthesis Industry Trends
2.2 Gene Synthesis Industry Drivers
2.3 Gene Synthesis Industry Opportunities and Challenges
2.4 Gene Synthesis Industry Restraints
3 GENE SYNTHESIS MARKET BY COMPANY
3.1 Global Gene Synthesis Company Revenue Ranking in 2023
3.2 Global Gene Synthesis Revenue by Company (2019-2024)
3.3 Global Gene Synthesis Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Gene Synthesis Company Manufacturing Base & Headquarters
3.5 Global Gene Synthesis Company, Product Type & Application
3.6 Global Gene Synthesis Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Gene Synthesis Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Gene Synthesis Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 GENE SYNTHESIS MARKET BY TYPE
4.1 Gene Synthesis Type Introduction
4.1.1 Below 1000 bp
4.1.2 1001-3000 bp
4.1.3 3001-5000 bp
4.1.4 Above 5000 bp
4.2 Global Gene Synthesis Sales Value by Type
4.2.1 Global Gene Synthesis Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Gene Synthesis Sales Value by Type (2019-2030)
4.2.3 Global Gene Synthesis Sales Value Share by Type (2019-2030)
5 GENE SYNTHESIS MARKET BY APPLICATION
5.1 Gene Synthesis Application Introduction
5.1.1 Commercial Research
5.1.2 Academic Research
5.2 Global Gene Synthesis Sales Value by Application
5.2.1 Global Gene Synthesis Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Gene Synthesis Sales Value by Application (2019-2030)
5.2.3 Global Gene Synthesis Sales Value Share by Application (2019-2030)
6 GENE SYNTHESIS MARKET BY REGION
6.1 Global Gene Synthesis Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Gene Synthesis Sales Value by Region (2019-2030)
6.2.1 Global Gene Synthesis Sales Value by Region: 2019-2024
6.2.2 Global Gene Synthesis Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Gene Synthesis Sales Value (2019-2030)
6.3.2 North America Gene Synthesis Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Gene Synthesis Sales Value (2019-2030)
6.4.2 Europe Gene Synthesis Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Gene Synthesis Sales Value (2019-2030)
6.5.2 Asia-Pacific Gene Synthesis Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Gene Synthesis Sales Value (2019-2030)
6.6.2 Latin America Gene Synthesis Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Gene Synthesis Sales Value (2019-2030)
6.7.2 Middle East & Africa Gene Synthesis Sales Value Share by Country, 2023 VS 2030
7 GENE SYNTHESIS MARKET BY COUNTRY
7.1 Global Gene Synthesis Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Gene Synthesis Sales Value by Country (2019-2030)
7.2.1 Global Gene Synthesis Sales Value by Country (2019-2024)
7.2.2 Global Gene Synthesis Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.3.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.4.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.5.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.6.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.7.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.8.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.9.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.10.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.11.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.12.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.13.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.14.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.15.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.16.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.17.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.18.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.19.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.20.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Gene Synthesis Sales Value Growth Rate (2019-2030)
7.21.2 Global Gene Synthesis Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Gene Synthesis Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Genescript
8.1.1 Genescript Comapny Information
8.1.2 Genescript Business Overview
8.1.3 Genescript Gene Synthesis Revenue and Gross Margin (2019-2024)
8.1.4 Genescript Gene Synthesis Product Portfolio
8.1.5 Genescript Recent Developments
8.2 GeneArt (Thermofischer)
8.2.1 GeneArt (Thermofischer) Comapny Information
8.2.2 GeneArt (Thermofischer) Business Overview
8.2.3 GeneArt (Thermofischer) Gene Synthesis Revenue and Gross Margin (2019-2024)
8.2.4 GeneArt (Thermofischer) Gene Synthesis Product Portfolio
8.2.5 GeneArt (Thermofischer) Recent Developments
8.3 IDT
8.3.1 IDT Comapny Information
8.3.2 IDT Business Overview
8.3.3 IDT Gene Synthesis Revenue and Gross Margin (2019-2024)
8.3.4 IDT Gene Synthesis Product Portfolio
8.3.5 IDT Recent Developments
8.4 DNA 2.0 (ATUM)
8.4.1 DNA 2.0 (ATUM) Comapny Information
8.4.2 DNA 2.0 (ATUM) Business Overview
8.4.3 DNA 2.0 (ATUM) Gene Synthesis Revenue and Gross Margin (2019-2024)
8.4.4 DNA 2.0 (ATUM) Gene Synthesis Product Portfolio
8.4.5 DNA 2.0 (ATUM) Recent Developments
8.5 OriGene
8.5.1 OriGene Comapny Information
8.5.2 OriGene Business Overview
8.5.3 OriGene Gene Synthesis Revenue and Gross Margin (2019-2024)
8.5.4 OriGene Gene Synthesis Product Portfolio
8.5.5 OriGene Recent Developments
8.6 BBI
8.6.1 BBI Comapny Information
8.6.2 BBI Business Overview
8.6.3 BBI Gene Synthesis Revenue and Gross Margin (2019-2024)
8.6.4 BBI Gene Synthesis Product Portfolio
8.6.5 BBI Recent Developments
8.7 Genewiz
8.7.1 Genewiz Comapny Information
8.7.2 Genewiz Business Overview
8.7.3 Genewiz Gene Synthesis Revenue and Gross Margin (2019-2024)
8.7.4 Genewiz Gene Synthesis Product Portfolio
8.7.5 Genewiz Recent Developments
8.8 Eurofins Genomics
8.8.1 Eurofins Genomics Comapny Information
8.8.2 Eurofins Genomics Business Overview
8.8.3 Eurofins Genomics Gene Synthesis Revenue and Gross Margin (2019-2024)
8.8.4 Eurofins Genomics Gene Synthesis Product Portfolio
8.8.5 Eurofins Genomics Recent Developments
8.9 Gene Oracle
8.9.1 Gene Oracle Comapny Information
8.9.2 Gene Oracle Business Overview
8.9.3 Gene Oracle Gene Synthesis Revenue and Gross Margin (2019-2024)
8.9.4 Gene Oracle Gene Synthesis Product Portfolio
8.9.5 Gene Oracle Recent Developments
8.10 SBS Genetech
8.10.1 SBS Genetech Comapny Information
8.10.2 SBS Genetech Business Overview
8.10.3 SBS Genetech Gene Synthesis Revenue and Gross Margin (2019-2024)
8.10.4 SBS Genetech Gene Synthesis Product Portfolio
8.10.5 SBS Genetech Recent Developments
8.11 Bio Basic
8.11.1 Bio Basic Comapny Information
8.11.2 Bio Basic Business Overview
8.11.3 Bio Basic Gene Synthesis Revenue and Gross Margin (2019-2024)
8.11.4 Bio Basic Gene Synthesis Product Portfolio
8.11.5 Bio Basic Recent Developments
9 CONCLUDING INSIGHTS
10 APPENDIX
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
LIST OF TABLES
Table 1. Gene Synthesis Industry Trends
Table 2. Gene Synthesis Industry Drivers
Table 3. Gene Synthesis Industry Opportunities and Challenges
Table 4. Gene Synthesis Industry Restraints
Table 5. Global Gene Synthesis Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Gene Synthesis Revenue Share by Company (2019-2024)
Table 7. Global Gene Synthesis Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 8. Global Gene Synthesis Key Company Manufacturing Base & Headquarters
Table 9. Global Gene Synthesis Company, Product Type & Application
Table 10. Global Gene Synthesis Company Commercialization Time
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Gene Synthesis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Major Companies of Below 1000 bp
Table 15. Major Companies of 1001-3000 bp
Table 16. Major Companies of 3001-5000 bp
Table 17. Major Companies of Above 5000 bp
Table 18. Global Gene Synthesis Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Gene Synthesis Sales Value by Type (2019-2024) & (US$ Million)
Table 20. Global Gene Synthesis Sales Value by Type (2025-2030) & (US$ Million)
Table 21. Global Gene Synthesis Sales Value Share by Type (2019-2024)
Table 22. Global Gene Synthesis Sales Value Share by Type (2025-2030)
Table 23. Major Companies of Commercial Research
Table 24. Major Companies of Academic Research
Table 25. Global Gene Synthesis Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 26. Global Gene Synthesis Sales Value by Application (2019-2024) & (US$ Million)
Table 27. Global Gene Synthesis Sales Value by Application (2025-2030) & (US$ Million)
Table 28. Global Gene Synthesis Sales Value Share by Application (2019-2024)
Table 29. Global Gene Synthesis Sales Value Share by Application (2025-2030)
Table 30. Global Gene Synthesis Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Global Gene Synthesis Sales Value by Region (2019-2024) & (US$ Million)
Table 32. Global Gene Synthesis Sales Value Share by Region (2019-2024)
Table 33. Global Gene Synthesis Sales Value by Region (2025-2030) & (US$ Million)
Table 34. Global Gene Synthesis Sales Value Share by Region (2025-2030)
Table 35. Global Gene Synthesis Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Global Gene Synthesis Sales Value by Country (2019-2024) & (US$ Million)
Table 37. Global Gene Synthesis Sales Value Market Share by Country (2019-2024)
Table 38. Global Gene Synthesis Sales Value by Country (2025-2030) & (US$ Million)
Table 39. Global Gene Synthesis Sales Value Market Share by Country (2025-2030)
Table 40. Genescript Company Information
Table 41. Genescript Business Overview
Table 42. Genescript Gene Synthesis Revenue (US$ Million) and Gross Margin (2019-2024)
Table 43. Genescript Gene Synthesis Product Portfolio
Table 44. Genescript Recent Development
Table 45. GeneArt (Thermofischer) Company Information
Table 46. GeneArt (Thermofischer) Business Overview
Table 47. GeneArt (Thermofischer) Gene Synthesis Revenue (US$ Million) and Gross Margin (2019-2024)
Table 48. GeneArt (Thermofischer) Gene Synthesis Product Portfolio
Table 49. GeneArt (Thermofischer) Recent Development
Table 50. IDT Company Information
Table 51. IDT Business Overview
Table 52. IDT Gene Synthesis Revenue (US$ Million) and Gross Margin (2019-2024)
Table 53. IDT Gene Synthesis Product Portfolio
Table 54. IDT Recent Development
Table 55. DNA 2.0 (ATUM) Company Information
Table 56. DNA 2.0 (ATUM) Business Overview
Table 57. DNA 2.0 (ATUM) Gene Synthesis Revenue (US$ Million) and Gross Margin (2019-2024)
Table 58. DNA 2.0 (ATUM) Gene Synthesis Product Portfolio
Table 59. DNA 2.0 (ATUM) Recent Development
Table 60. OriGene Company Information
Table 61. OriGene Business Overview
Table 62. OriGene Gene Synthesis Revenue (US$ Million) and Gross Margin (2019-2024)
Table 63. OriGene Gene Synthesis Product Portfolio
Table 64. OriGene Recent Development
Table 65. BBI Company Information
Table 66. BBI Business Overview
Table 67. BBI Gene Synthesis Revenue (US$ Million) and Gross Margin (2019-2024)
Table 68. BBI Gene Synthesis Product Portfolio
Table 69. BBI Recent Development
Table 70. Genewiz Company Information
Table 71. Genewiz Business Overview
Table 72. Genewiz Gene Synthesis Revenue (US$ Million) and Gross Margin (2019-2024)
Table 73. Genewiz Gene Synthesis Product Portfolio
Table 74. Genewiz Recent Development
Table 75. Eurofins Genomics Company Information
Table 76. Eurofins Genomics Business Overview
Table 77. Eurofins Genomics Gene Synthesis Revenue (US$ Million) and Gross Margin (2019-2024)
Table 78. Eurofins Genomics Gene Synthesis Product Portfolio
Table 79. Eurofins Genomics Recent Development
Table 80. Gene Oracle Company Information
Table 81. Gene Oracle Business Overview
Table 82. Gene Oracle Gene Synthesis Revenue (US$ Million) and Gross Margin (2019-2024)
Table 83. Gene Oracle Gene Synthesis Product Portfolio
Table 84. Gene Oracle Recent Development
Table 85. SBS Genetech Company Information
Table 86. SBS Genetech Business Overview
Table 87. SBS Genetech Gene Synthesis Revenue (US$ Million) and Gross Margin (2019-2024)
Table 88. SBS Genetech Gene Synthesis Product Portfolio
Table 89. SBS Genetech Recent Development
Table 90. Bio Basic Company Information
Table 91. Bio Basic Business Overview
Table 92. Bio Basic Gene Synthesis Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Bio Basic Gene Synthesis Product Portfolio
Table 94. Bio Basic Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Authors List of This Report
Table 97. Secondary Sources
Table 98. Primary Sources
Table 1. Gene Synthesis Industry Trends
Table 2. Gene Synthesis Industry Drivers
Table 3. Gene Synthesis Industry Opportunities and Challenges
Table 4. Gene Synthesis Industry Restraints
Table 5. Global Gene Synthesis Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Gene Synthesis Revenue Share by Company (2019-2024)
Table 7. Global Gene Synthesis Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 8. Global Gene Synthesis Key Company Manufacturing Base & Headquarters
Table 9. Global Gene Synthesis Company, Product Type & Application
Table 10. Global Gene Synthesis Company Commercialization Time
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Gene Synthesis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Major Companies of Below 1000 bp
Table 15. Major Companies of 1001-3000 bp
Table 16. Major Companies of 3001-5000 bp
Table 17. Major Companies of Above 5000 bp
Table 18. Global Gene Synthesis Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Gene Synthesis Sales Value by Type (2019-2024) & (US$ Million)
Table 20. Global Gene Synthesis Sales Value by Type (2025-2030) & (US$ Million)
Table 21. Global Gene Synthesis Sales Value Share by Type (2019-2024)
Table 22. Global Gene Synthesis Sales Value Share by Type (2025-2030)
Table 23. Major Companies of Commercial Research
Table 24. Major Companies of Academic Research
Table 25. Global Gene Synthesis Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 26. Global Gene Synthesis Sales Value by Application (2019-2024) & (US$ Million)
Table 27. Global Gene Synthesis Sales Value by Application (2025-2030) & (US$ Million)
Table 28. Global Gene Synthesis Sales Value Share by Application (2019-2024)
Table 29. Global Gene Synthesis Sales Value Share by Application (2025-2030)
Table 30. Global Gene Synthesis Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Global Gene Synthesis Sales Value by Region (2019-2024) & (US$ Million)
Table 32. Global Gene Synthesis Sales Value Share by Region (2019-2024)
Table 33. Global Gene Synthesis Sales Value by Region (2025-2030) & (US$ Million)
Table 34. Global Gene Synthesis Sales Value Share by Region (2025-2030)
Table 35. Global Gene Synthesis Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Global Gene Synthesis Sales Value by Country (2019-2024) & (US$ Million)
Table 37. Global Gene Synthesis Sales Value Market Share by Country (2019-2024)
Table 38. Global Gene Synthesis Sales Value by Country (2025-2030) & (US$ Million)
Table 39. Global Gene Synthesis Sales Value Market Share by Country (2025-2030)
Table 40. Genescript Company Information
Table 41. Genescript Business Overview
Table 42. Genescript Gene Synthesis Revenue (US$ Million) and Gross Margin (2019-2024)
Table 43. Genescript Gene Synthesis Product Portfolio
Table 44. Genescript Recent Development
Table 45. GeneArt (Thermofischer) Company Information
Table 46. GeneArt (Thermofischer) Business Overview
Table 47. GeneArt (Thermofischer) Gene Synthesis Revenue (US$ Million) and Gross Margin (2019-2024)
Table 48. GeneArt (Thermofischer) Gene Synthesis Product Portfolio
Table 49. GeneArt (Thermofischer) Recent Development
Table 50. IDT Company Information
Table 51. IDT Business Overview
Table 52. IDT Gene Synthesis Revenue (US$ Million) and Gross Margin (2019-2024)
Table 53. IDT Gene Synthesis Product Portfolio
Table 54. IDT Recent Development
Table 55. DNA 2.0 (ATUM) Company Information
Table 56. DNA 2.0 (ATUM) Business Overview
Table 57. DNA 2.0 (ATUM) Gene Synthesis Revenue (US$ Million) and Gross Margin (2019-2024)
Table 58. DNA 2.0 (ATUM) Gene Synthesis Product Portfolio
Table 59. DNA 2.0 (ATUM) Recent Development
Table 60. OriGene Company Information
Table 61. OriGene Business Overview
Table 62. OriGene Gene Synthesis Revenue (US$ Million) and Gross Margin (2019-2024)
Table 63. OriGene Gene Synthesis Product Portfolio
Table 64. OriGene Recent Development
Table 65. BBI Company Information
Table 66. BBI Business Overview
Table 67. BBI Gene Synthesis Revenue (US$ Million) and Gross Margin (2019-2024)
Table 68. BBI Gene Synthesis Product Portfolio
Table 69. BBI Recent Development
Table 70. Genewiz Company Information
Table 71. Genewiz Business Overview
Table 72. Genewiz Gene Synthesis Revenue (US$ Million) and Gross Margin (2019-2024)
Table 73. Genewiz Gene Synthesis Product Portfolio
Table 74. Genewiz Recent Development
Table 75. Eurofins Genomics Company Information
Table 76. Eurofins Genomics Business Overview
Table 77. Eurofins Genomics Gene Synthesis Revenue (US$ Million) and Gross Margin (2019-2024)
Table 78. Eurofins Genomics Gene Synthesis Product Portfolio
Table 79. Eurofins Genomics Recent Development
Table 80. Gene Oracle Company Information
Table 81. Gene Oracle Business Overview
Table 82. Gene Oracle Gene Synthesis Revenue (US$ Million) and Gross Margin (2019-2024)
Table 83. Gene Oracle Gene Synthesis Product Portfolio
Table 84. Gene Oracle Recent Development
Table 85. SBS Genetech Company Information
Table 86. SBS Genetech Business Overview
Table 87. SBS Genetech Gene Synthesis Revenue (US$ Million) and Gross Margin (2019-2024)
Table 88. SBS Genetech Gene Synthesis Product Portfolio
Table 89. SBS Genetech Recent Development
Table 90. Bio Basic Company Information
Table 91. Bio Basic Business Overview
Table 92. Bio Basic Gene Synthesis Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Bio Basic Gene Synthesis Product Portfolio
Table 94. Bio Basic Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Authors List of This Report
Table 97. Secondary Sources
Table 98. Primary Sources
LIST OF FIGURES
Figure 1. Gene Synthesis Product Picture
Figure 2. Global Gene Synthesis Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Gene Synthesis Market Size (2019-2030) & (US$ Million)
Figure 4. Global Gene Synthesis Company Revenue Ranking in 2023 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 7. Below 1000 bp Picture
Figure 8. 1001-3000 bp Picture
Figure 9. 3001-5000 bp Picture
Figure 10. Above 5000 bp Picture
Figure 11. Global Gene Synthesis Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Gene Synthesis Sales Value Share 2019 VS 2023 VS 2030
Figure 13. Global Gene Synthesis Sales Value Share by Type (2019-2030)
Figure 14. Commercial Research Picture
Figure 15. Academic Research Picture
Figure 16. Global Gene Synthesis Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Gene Synthesis Sales Value Share 2019 VS 2023 VS 2030
Figure 18. Global Gene Synthesis Sales Value Share by Application (2019-2030)
Figure 19. Global Gene Synthesis Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 20. Global Gene Synthesis Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 21. North America Gene Synthesis Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Gene Synthesis Sales Value Share by Country (%), 2023 VS 2030
Figure 23. Europe Gene Synthesis Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Gene Synthesis Sales Value Share by Country (%), 2023 VS 2030
Figure 25. Asia-Pacific Gene Synthesis Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia-Pacific Gene Synthesis Sales Value Share by Country (%), 2023 VS 2030
Figure 27. Latin America Gene Synthesis Sales Value (2019-2030) & (US$ Million)
Figure 28. Latin America Gene Synthesis Sales Value Share by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Gene Synthesis Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Gene Synthesis Sales Value Share by Country (%), 2023 VS 2030
Figure 31. USA Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 32. USA Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 33. USA Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 34. Canada Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 35. Canada Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 36. Canada Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 37. Germany Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 38. Germany Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 39. Germany Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 40. France Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 41. France Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 42. France Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 43. U.K. Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 44. U.K. Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 45. U.K. Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 46. Italy Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 47. Italy Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 48. Italy Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 49. Netherlands Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 50. Netherlands Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 51. Netherlands Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 52. Nordic Countries Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 53. Nordic Countries Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 54. Nordic Countries Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 55. China Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 56. China Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 57. China Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 58. Japan Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 59. Japan Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 60. Japan Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 61. South Korea Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 62. South Korea Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 63. South Korea Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 64. Southeast Asia Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 65. Southeast Asia Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 66. Southeast Asia Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 67. India Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 68. India Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 69. India Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 70. Australia Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 71. Australia Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 72. Australia Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 73. Mexico Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 74. Mexico Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 75. Mexico Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 76. Brazil Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 77. Brazil Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 78. Brazil Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 79. Turkey Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 80. Turkey Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 81. Turkey Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 82. Saudi Arabia Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 83. Saudi Arabia Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 84. Saudi Arabia Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 85. UAE Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 86. UAE Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 87. UAE Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 88. Years Considered
Figure 89. Research Process
Figure 90. Key Executives Interviewed
Figure 1. Gene Synthesis Product Picture
Figure 2. Global Gene Synthesis Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Gene Synthesis Market Size (2019-2030) & (US$ Million)
Figure 4. Global Gene Synthesis Company Revenue Ranking in 2023 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 7. Below 1000 bp Picture
Figure 8. 1001-3000 bp Picture
Figure 9. 3001-5000 bp Picture
Figure 10. Above 5000 bp Picture
Figure 11. Global Gene Synthesis Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Gene Synthesis Sales Value Share 2019 VS 2023 VS 2030
Figure 13. Global Gene Synthesis Sales Value Share by Type (2019-2030)
Figure 14. Commercial Research Picture
Figure 15. Academic Research Picture
Figure 16. Global Gene Synthesis Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Gene Synthesis Sales Value Share 2019 VS 2023 VS 2030
Figure 18. Global Gene Synthesis Sales Value Share by Application (2019-2030)
Figure 19. Global Gene Synthesis Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 20. Global Gene Synthesis Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 21. North America Gene Synthesis Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Gene Synthesis Sales Value Share by Country (%), 2023 VS 2030
Figure 23. Europe Gene Synthesis Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Gene Synthesis Sales Value Share by Country (%), 2023 VS 2030
Figure 25. Asia-Pacific Gene Synthesis Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia-Pacific Gene Synthesis Sales Value Share by Country (%), 2023 VS 2030
Figure 27. Latin America Gene Synthesis Sales Value (2019-2030) & (US$ Million)
Figure 28. Latin America Gene Synthesis Sales Value Share by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Gene Synthesis Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Gene Synthesis Sales Value Share by Country (%), 2023 VS 2030
Figure 31. USA Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 32. USA Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 33. USA Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 34. Canada Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 35. Canada Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 36. Canada Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 37. Germany Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 38. Germany Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 39. Germany Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 40. France Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 41. France Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 42. France Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 43. U.K. Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 44. U.K. Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 45. U.K. Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 46. Italy Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 47. Italy Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 48. Italy Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 49. Netherlands Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 50. Netherlands Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 51. Netherlands Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 52. Nordic Countries Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 53. Nordic Countries Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 54. Nordic Countries Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 55. China Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 56. China Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 57. China Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 58. Japan Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 59. Japan Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 60. Japan Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 61. South Korea Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 62. South Korea Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 63. South Korea Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 64. Southeast Asia Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 65. Southeast Asia Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 66. Southeast Asia Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 67. India Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 68. India Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 69. India Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 70. Australia Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 71. Australia Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 72. Australia Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 73. Mexico Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 74. Mexico Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 75. Mexico Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 76. Brazil Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 77. Brazil Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 78. Brazil Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 79. Turkey Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 80. Turkey Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 81. Turkey Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 82. Saudi Arabia Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 83. Saudi Arabia Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 84. Saudi Arabia Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 85. UAE Gene Synthesis Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 86. UAE Gene Synthesis Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 87. UAE Gene Synthesis Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 88. Years Considered
Figure 89. Research Process
Figure 90. Key Executives Interviewed
